In this commentary, Kimberly DeQuattro, MD, from University of California, San Francisco, highlights key considerations when managing a patient with SLE who may want to become pregnant, how to address...
Bruce Rothschild, MD, from Indiana University Ball Memorial Hospital, discusses the importance of monitoring janus kinase inhibitor use in rheumatic diseases, the role of antiphospholipid antibodies for...
Sheila T. Angeles-Han, MD, MSc, lead author of the 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic...
Sheila T. Angeles-Han, MD, MSc, lead author of the 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic...
In this video, Karen Onel, MD, explains why the ACR's most recent recommendations are needed as well as what new areas they address that had not been included in past guidelines.
In this commentary, Saira Sheikh, MD, from the University of North Carolina at Chapel Hill, discusses the lack of diversity in lupus clinical trials and how it can negatively impact patients’ rheumatologic...
In this commentary, Christie Bartels, MD, MS, from the University of Wisconsin discusses findings of a recently published cross-sectional study that evaluated malignancy risk among patients with SLE...
Christine Peoples, MD, from University of Pittsburgh Medical Center, discusses telemedicine in a rheumatology setting, its impact on care amidst the shortage of rheumatologists, and more.
In this commentary, Vikas Majithia, MD, MPH, explains results of the PEXIVAS study and how they will impact the way rheumatologists treat patients with anti-neutrophil cytoplasm antibody-associated...
